Primer on Medical Genomics: Part XII: Pharmacogenomics—General Principles With Cancer as a Model
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (3), 376-384
- https://doi.org/10.4065/79.3.376
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicityThe Pharmacogenomics Journal, 2002
- The Sequence of the Human GenomeScience, 2001
- Human DNA Repair GenesScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Structure, Recognition, and Processing of Cisplatin−DNA AdductsChemical Reviews, 1999
- Ethnic Variation in the Thymidylate Synthase Enhancer Region Polymorphism among Caucasian and Asian PopulationsGenomics, 1999
- The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populationsPharmacogenetics, 1999
- Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.Cell Structure and Function, 1995
- Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil ToxicityNew England Journal of Medicine, 1985
- SOME STATISTICAL DATA ON ATYPICAL CHOLINESTERASE OF HUMAN SERUMAnnals of Human Genetics, 1959